Cost-Effectiveness of Various Interventions for Newly Diagnosed Diabetic Macular Edema
Stein JD, Newman-Casey PA, Kim DD, Nwanyanwu KH, Johnson MW, Hutton DW. Cost-Effectiveness of Various Interventions for Newly Diagnosed Diabetic Macular Edema. Ophthalmology 2013, 120: 1835-1842. PMID: 23642372, PMCID: PMC3737388, DOI: 10.1016/j.ophtha.2013.02.002.Peer-Reviewed Original ResearchMeSH KeywordsAngiogenesis InhibitorsAntibodies, Monoclonal, HumanizedBevacizumabCombined Modality TherapyCost-Benefit AnalysisDiabetic RetinopathyDiagnostic Techniques, OphthalmologicalDrug CostsFinancing, PersonalGlucocorticoidsHealth Care CostsHumansIntravitreal InjectionsLaser CoagulationMacular EdemaMarkov ChainsMiddle AgedQuality-Adjusted Life YearsRanibizumabTriamcinolone AcetonideVascular Endothelial Growth Factor AConceptsQuality-adjusted life yearsProbabilistic sensitivity analysesTime horizonSensitivity analysisCost-effectiveness analysisWTP valuesCost-effective treatment optionLife yearsIncremental costMedicare fee scheduleWTPHypothetical cohortFee scheduleCSDMECostHorizonFinancialMarkov modelWillingnessOptions